Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Anticancer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 25550569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma

  2013cited by this paper
• Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

  2013cited by this paper
• Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer

  2012cited by this paper
• Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma.

  2012cited by this paper
• Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Effects of Gender on White Blood Cell Populations and Neutrophil-Lymphocyte Ratio Following Gastrectomy in Patients with Stomach Cancer

  2007cited by this paper
• Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer

  2005cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process.

  1997cited by this paper
• The codependence of angiogenesis and chronic inflammation

  1997cited by this paper
• Value of Preoperative CA 125 Level in the Management of Uterine Cancer and Prediction of Clinical Outcome

  1997cited by this paper
• Serial Serum CA 125 Measurements for Evaluation of Recurrence in Patients With Endometrial Carcinoma

  1994cited by this paper
• Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.

  1994cited by this paper
• Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma.

  1990cited by this paper
• Tumor Markers CA 125, Squamous Cell Carcinoma Antigen, and Carcinoembryonic Antigen in Patients With Adenocarcinoma of the Uterine Cervix

  1989cited by this paper
• CA 125: A useful marker in endometrial carcinoma

  1987cited by this paper
• Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

  1986cited by this paper
• Platelet alpha-granule proteins: studies on release and subcellular localization.

  1979cited by this paper

• Prognostic Significance of Neutrophil‐to‐Lymphocyte Ratio in Melanoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen

  2025cites this paper
• Neutrophil to Lymphocyte Ratio a Prognostic Tool in Endometrial Cancer Among Classical Prognostic Factors

  2025influential citation
• Clinical Correlations between Serological Markers and Endometrial Cancer

  2024cites this paper
• The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors

  2024cites this paper
• Diagnostic, prognostic, and predictive importance of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and CA125 in endometrial hyperplasia and carcinoma.

  2024cites this paper
• Nomogram Based on Immune-Inflammatory Score and Classical Clinicopathological Parameters for Predicting the Recurrence of Endometrial Carcinoma: A Large, Multi-Center Retrospective Study

  2024cites this paper
• Evaluating pretreatment serum CA-125 levels as prognostic biomarkers in endometrial cancer: a comprehensive meta-analysis

  2024cites this paper
• Pre-Operative Neutrophil-to-Lymphocyte Ratio as a Predictor of Post-Operative Infectious Morbidity in Gynecologic Oncology Patients

  2023cites this paper
• Comparison of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio levels in ovarian cyst among epithelial ovarian cancer patients at RSUP H. Adam Malik Medan, Indonesia

  2023cites this paper
• Hematologic inflammatory indexes as a prognostic factor in endometrial cancer grading and staging

  2023cites this paper
• Preoperative Prognostic Nutritional Index Is a Prognostic Indicator of Cancer-Specific Survival in Patients Undergoing Endometrial Cancer Surgery

  2023cites this paper
• Predictive value of hemogram parameters in malignant transformation of the endometrium in patients with different risk factors

  2023cites this paper
• The comparison of inflammatory markers in geriatric and nongeriatric endometrial cancers

  2022cites this paper
• Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease

  2022cites this paper
• Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer

  2022cites this paper
• Study on Preoperative Neutrophil/Lymphocyte (NLR) and Platelet/Lymphocyte Ratio (PLR) as a Predictive Factor in Endometrial Cancer

  2022influential citation
• The value of clinical symptoms, the neutrophil‐to‐lymphocyte ratio, and ultrasonographic features in predicting adnexal torsion: A case–control study

  2022cites this paper
• Are blood parameters assessed before taking frozen sections useful in gynecological oncology?

  2022cites this paper
• Correlation of bone marrow 2-deoxy-2-[18F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer

  2022cites this paper
• Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis

  2022influential citation
• Complete blood count parameters, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in hydatidiform mole versus missed abortion

  2022cites this paper
• Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies – State of the Art

  2021cites this paper
• New Insights into Endometrial Cancer

  2021cites this paper
• Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer

  2021cites this paper
• Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis

  2021cites this paper
• Comparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia.

  2021cites this paper
• CMAR_A_312828 5491..5508

  2021cites this paper
• Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.

  2020cites this paper
• The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.

  2020cites this paper
• Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy

  2020cites this paper
• The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis

  2020cites this paper
• Inflammatory prognostic markers in endometrial carcinoma: Systemic immune-inflammation index and prognostic nutritional index

  2020cites this paper
• Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

  2019cites this paper
• Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis

  2019influential citation
• Platelet–lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis

  2019cites this paper
• Prognostic function of platelet-to-lymphocyte ratio in gynecologic cancers: A systematic review and meta-analysis

  2019cites this paper
• Neutrophilia and mortality in women with uterine carcinosarcoma

  2019cites this paper
• The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer

  2019cites this paper
• Platelet to lymphocyte and neutrophil to lymphocyte ratio as predictive indices of endometrial carcinoma: Findings from a retrospective series of patients and meta-analysis.

  2018cites this paper
• New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer

  2018cites this paper
• Endometrium Kanserli Hastalarda Preoperatif Tam Kan Sayımının Prognostik Parametreler ve Sağkalımla İlişkisi

  2018cites this paper
• Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.

  2018cites this paper
• Diagnostic value of neutrophil to lymphocyte ratio in differentiation of ruptured ovarian cysts and adnexal torsion

  2018cites this paper
• Predictive Value of Hematological Inflammatory Markers in Endometrial Neoplasia

  2018cites this paper
• Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio

  2018influential citation
• Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.

  2018cites this paper
• Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.

  2017cites this paper
• Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients

  2017cites this paper
• BMI and outcomes of endometrial and ovarian cancer patients

  2016cites this paper
• Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.

  2016cites this paper
• The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian Cancer

  2016cites this paper
• Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors

  2016cites this paper
• The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer

  2016influential citation
• Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma

  2015cites this paper
• Neutrophil to Lymphocyte ratio in the diagnosis of adnexal torsion.

  2015cites this paper
• Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival

  2015cites this paper
• Original Article Neutrophil to Lymphocyte ratio in the diagnosis of adnexal torsion

  2015cites this paper